九洲药业2025年第一季度净利润同比增长5.68% CDMO业务稳步提升

证券日报网
15 Apr

本报讯(记者邬霁霞见习记者王楠)4月15日,浙江九洲药业股份有限公司(以下简称“九洲药业”)发布了2025年第一季度报告,公司实现营业收入14.90亿元,同比增长0.98%;归属于上市公司股东的净利润为2.50亿元,同比增长5.68%;归属于上市公司股东的扣除非经常性损益的净利润为2.51亿元,同比增长7.17%。九洲药业的业绩增长主要得益于其CDMO(合同开发和生产组织)业务的稳步增长。公司客户...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10